Optimizing the use of vilobelimab for the treatment of COVID-19
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - July 10, 2023 Category: Drugs & Pharmacology Authors: Matthew W McCarthyDepartment of Medicine, Weill Cornell Medicine, New York, NY, United States of America Source Type: research

Correction
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - July 7, 2023 Category: Drugs & Pharmacology Source Type: research

Monoclonal antibodies for the management of central nervous system diseases: clinical success and future strategies
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - June 28, 2023 Category: Drugs & Pharmacology Authors: Avtar Singh Gautam Shivam Kumar Pandey Vaibhav Lasure Sachin Dubey Rakesh Kumar Singh Source Type: research

Progress towards the clinical use of antimicrobial peptides: challenges and opportunities
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - June 27, 2023 Category: Drugs & Pharmacology Authors: Paula Espinal Ester Fust é Josep M. Sierra Guadalupe Jim énez-Galisteo Teresa Vinuesa Miguel Vi ñas Source Type: research

The future of CAR T-cell therapy for B-cell acute lymphoblastic leukemia in pediatrics and adolescents
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - June 23, 2023 Category: Drugs & Pharmacology Authors: Liora Schultz Crystal L Mackall Source Type: research

Culturing human pluripotent stem cells for regenerative medicine
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - June 23, 2023 Category: Drugs & Pharmacology Authors: Hiroki Ozawa Takuya Matsumoto Masato Nakagawa Source Type: research

The role of immune checkpoint inhibitors for patients with advanced stage microsatellite stable colorectal cancer and high tumor mutation burden: quantity or quality?
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - June 19, 2023 Category: Drugs & Pharmacology Authors: Charan Thej Reddy Vegivinti Cyndi Gonzales Gomez Masood Syed Morgan Ferrell Svea Cheng Aatur Singhi Anwaar Saeed Ibrahim Halil Sahin Source Type: research

Neutralizing anti-spike monoclonal antibodies for COVID-19 in vulnerable populations: lessons learned and future directions
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - June 19, 2023 Category: Drugs & Pharmacology Authors: Raymund R Razonable Source Type: research

Head and neck atopic dermatitis: still a challenging manifestation in the biologic era
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - June 14, 2023 Category: Drugs & Pharmacology Authors: Niccol ò Gori Elena Ippoliti Ketty Peris Andrea Chiricozzi Source Type: research

Is sotatercept, which traps activins and growth differentiation factors, a new dawn in treating pulmonary arterial hypertension (PAH)?
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - June 8, 2023 Category: Drugs & Pharmacology Authors: Sheila A Doggrell Source Type: research

Belantamab mafodotin in multiple myeloma
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - May 27, 2023 Category: Drugs & Pharmacology Authors: Enrica Antonia MartinoAntonella BruzzeseEnrico IaccinoCaterina LabancaFrancesco MendicinoSelena MimmiEugenio LuciaVirginia OlivitoAntonino NeriFortunato MorabitoErnesto VignaMassimo Gentilea Hematology Unit, Azienda Ospedaliera Annunziata, Cosenza, Italyb Source Type: research

Nivolumab + relatlimab for the treatment of unresectable or metastatic melanoma
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - May 24, 2023 Category: Drugs & Pharmacology Authors: Hanna Kose ła-Paterczyk Piotr Rutkowski Source Type: research